Over the last few years Prostate Cancer Research has grown significantly increasing the number of academic research projects we fund from 4 to 11 whilst placing collaboration and patient voice at the heart of our research strategy. Deep engagement with our patient population in recent years has highlighted a desire for Prostate Cancer Research to fund work that can deliver new treatments with a greater sense of urgency. As a result, we make sure that any research we fund has a clear roadmap to the clinic. Furthermore, we are also looking to increase our funding of later stage research, including in a commercial setting.
Like all organisations Covid-19 has impacted fundraising. However, thanks to a strong financial base, a forward thinking board and flexible staff team we have been able to spend the last 12 months building internal structures, creating new relationships and focusing on potential areas of growth. A new Translational Research Director is now required to bring a scientific, innovative and commercial approach to transform the impact PCR can have in academic and translational research for prostate cancer.
The two areas which the Translational Research Director (TRD) will be required to lead on are;
• The scientific lead when developing commercial partnerships.
The successful candidate will be the scientific lead on creating new industry relationships and identifying opportunities to translate our academic research into commercial opportunities. This could include linking with biotechs, pharmaceuticals and governments for licensing, spinning out, or clinical trials. You will understand the cross over between industry priorities and PCR’s research, identify where PCR can add value and then work alongside the fundraising team to secure new funding.
• The creation of a translational research fund focused on prostate cancer.
The Translational Director will be responsible for identifying the best academic research with commercial potential as well as identify companies with existing oncology assets that could be successful utilised for new treatments or diagnostics for prostate cancer. The TRD will lead on establishing this new fund either through working with an external fund manager or setting up a fund internally.
The successful candidate will be someone who has a strong understanding of oncology, along with an innovative and commercial approach to transforming the impact PCR can have in academic and translational research.
• Position PCR as the key partner to work with in the prostate cancer field.
• Identify therapeutic pipeline opportunities that correlate with PCR’s project portfolio.
• Ensure the organisation identifies opportunities for research and educational partnerships to co-fund or create new projects with external partners. These could include biotechs, large pharma or investors.
• You will be the scientific lead to enable us to create new partnerships. You will work alongside the CEO, Head of Research and Communications, Head of Major Gifts and Head of Partnerships to realise collaborative funding deals, educational grants for specific projects and sponsorship agreements.
• Identify potential reputational risks and implement appropriate risk mitigation when developing joint projects.
Project Management of commercial partnership projects
• Ensure that any joint project with a commercial partner is kicked off and that the delivery team understand the nature of the relationship with the partner and key deliverables.
• Ensure that projects are sufficiently and appropriately resourced.
• Take an overview of the management of all live projects, ensuring that relevant meetings take place - initiation, mid-project update, data processing and final evaluation.
• Keep abreast of outstanding proposals to foresee and plan workload levels.
Creation of a Translational Research Fund
• Create a portfolio of investment opportunities in both diagnostics and therapeutics and carry out the required analysis and due diligence of any given opportunity.
• Help to select an external fund manager who we will work alongside to raise circa £40-£60m to invest in translational research and/or help to set up an internal fund to invest in early stage research.
• Work alongside the fundraising team to find a cornerstone investor for this fund.
• Work with an investment committee and potentially an external fund manager to find, select and support seed funded companies and more established firms as necessary.
• Be the bridge between PCR and an external fund manager/committee.
Act as a key member of leadership team of PCRC
• Work together with other senior staff to provide leadership for the organisation.
• Have an input on the overall direction of the organisation and contribute to the growth and success of the charity.
• Identify key areas for organisational development which will provide better opportunities for the organisation to meet its goals.
• Take a lead role in establishing development plans for the more junior members of the team.
• Educated to MSc or PhD level in relevant medical sciences.
• Significant experience of translational research as an investor, or director level experience at biotech or pharmaceutical.
• Strong understanding of the oncology pharma world and ability to think creatively around new ways to create prostate cancer breakthroughs playing to our strengths
• Significant experience of working effectively with other organisations.
• Project management experience – experience of having overall responsibility for delivering on significant projects.
• Understanding of the investment landscape and significant financial acumen.
• Entrepreneurial mind-set – ability to overcome challenges, high level of motivation and strong decision making.
• Focus on impact for people with Prostate Cancer.
Location: Flexible - will be based at home to start with, and then time can be split between home and our offices in London
To apply please send a cv and covering letter stating why you are suitable for the role